Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Time to a significant change of antimicrobial therapy from the time of the diagnosis of sepsis or septic shock
研究概览
简要总结
With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock.
Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with a new diagnosed sepsis or septic shock: emergency department, operating theatre, intensive care unit and planed blood culture diagnostics.
- •informed written consent
排除标准
- •Pediatric patients (< 18 Years)
- •DNR-order
结局指标
主要结局
Time to a significant change of antimicrobial therapy from the time of the diagnosis of sepsis or septic shock
时间窗: Nov. 2016 - Nov. 2017
次要结局
未报告次要终点
研究者
Sven-Olaf Kuhn
Sven-Olaf Kuhn MD
University Medicine Greifswald